Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: Antitumor effects, in vivo fate, and tumor cell mutants

P. E. Thorpe, D. C. Blakey, A. N F Brown, P. P. Knowles, R. E. Knyba, P. M. Wallace, G. J. Watson, E. J. Wawrzynczak